The Department of Medicine 4 is a member of a worldwide consortium that has the aim of improving treatment of chronic kidney disease.
Researchers at the Department of Neurology demonstrated the significant influence of new signal paths of the renin-angiotensin system (RAS).
FAU has demonstrated its strength in research once again: the University is conducting a new research project together with Siemens Healthcare GmbH, Universitätsklinikum Erlangen and other European partners in which researchers will develop an innovative hybrid device that combines different medical imaging technologies and will help stroke patients in particular to receive quicker diagnosis and treatment.
Dendritic cells represent an important component of the immune system: they recognize and engulf invaders which subsequently triggers a pathogen-specific immune response. Scientists of the Department of Dermatology and the LIMES Institute of the University of Bonn gained substantial knowledge of human dendritic cells which might contribute to the development of immune therapies in the future.
The Faculty of Medicine welcomes another Humboldt fellow at the Department of Medicine 1, Dr. J. Patankar.
Prof. Norbert J. Pelc, ScD, Stanford University, California, was conferred the degree Doktor der Medizin honoris causa (Dr. med. h.c.).
A delegation of the Kasr Alainy Faculty of Medicine, Cairo University, visited our Faculty from 18 - 20 July 2016. Aim of the visit was to start a research cooperation between the Kasr Alainy Faculty of Medicine and the Interdisciplinary Center of Public Health to evaluate health technologies.
Around 120 scientists and physicians from different European countries, the US, and Brazil met in Erlangen from July 6 - 9th to take part in the Summer School "Translational kidney research – from physiology to clinical application“.
A team of researchers has taken some important steps towards finding treatments for a specific form of hereditary spastic paraplegia, a group of neurodegenerative diseases for which there is currently no known cure.
Researchers at the Institute of Physiology and Pathophysiology and at the Department of Medicine 1 have identified another substance that could be just as effective at combating severe pain, but is much more easily tolerated.